Skip to content

Huashan Hospital REM Sleep Behavior Disorder Cohort(HSRBDCo)

Huashan Hospital REM Sleep Behavior Disorder Cohort(HSRBDCo)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100748
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-04-15
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

REM Sleep Behavior Disorder (RBD) is a type of parasomnia characterized by dream enactive behaviors and REM sleep without atonia (RSWA). It is divided into two main categories: idiopathic RBD (iRBD) and secondary RBD. iRBD has no obvious neurological symptoms and signs, but there is a pathological basis of alpha-synucleinopathy,and there is a risk of developing Parkinson's disease, multiple system

Interventions

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria for RBD; 2.No gender limitation, with an age is greater than or equal to 18 years old; 3.Having normal comprehension and language expression abilities to communicate with the researchers and being able to complete the questionnaire items successfully.

Exclusion criteria

Exclusion criteria: 1.Suffering from severe somatic diseases, such as those affecting the heart, liver, or kidneys; 2.Having unstable psychiatric disorders; 3.Having a history of alcohol abuse or substance dependence.

Design outcomes

Primary

MeasureTime frame
Identification of predictors of phenoconversion in patients with RBD;

Secondary

MeasureTime frame
Description of the demographic and clinical characteristics of patients diagnosed with RBD;Assessment of the correlation between electrophysiological indicators and phenoconversion.;Assessment of the correlation between therapeutic interventions, lifestyle, and phenoconversion.;Collection of longitudinal data about the development of RBD and estimation of the conversion time and rate.;Therapeutic intervention efficacy evaluation indicators.;Evaluation of the impact of RBD on daytime function, sleep quality, and cognitive function.;Identification of RBD phenotypes through different biomarkers.;

Countries

China

Contacts

Public ContactYu Huan

Huashan Hospital, Fudan University

dr.yuhuan@163.com+86 21 54602179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026